supp.fit

Chromium: study protocols

65 study groups say how much Chromium participants took a day. These are the doses the studies gave. They are not a recommendation.

Chromium: what the research found →

Dose per serving from products

10,171 products in our catalogue print how much Chromium a serving holds.

Most common: 100 mcg to 250 mcg, 30% of 10,171 products.

Dose per servingProducts
1 mcg or less
123
1 mcg to 2.5 mcg
388
2.5 mcg to 5 mcg
291
5 mcg to 10 mcg
517
10 mcg to 25 mcg
1,277
25 mcg to 50 mcg
1,819
50 mcg to 100 mcg
1,678
100 mcg to 250 mcg
3,070
250 mcg to 500 mcg
408
500 mcg to 1 mg
237
over 1 mg
363

Dose per serving from research

64 study groups in 50 studies say how much Chromium participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg and 500 mcg to 1 mg, 28% of 64 study groups each.

Daily doseStudy groups
25 mcg or less
4
25 mcg to 50 mcg
2
50 mcg to 100 mcg
1
100 mcg to 250 mcg
14
250 mcg to 500 mcg
18
500 mcg to 1 mg
18
1 mg to 2.5 mg
1
2.5 mg to 5 mg
2
5 mg to 10 mg
0
10 mg to 25 mg
0
25 mg to 50 mg
1
over 50 mg
3

Commonly used together

19 of 65 study groups took Chromium with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Gymnema Sylvestre
3

65 study groups

Study
The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial
2016 · chromium group · Women with polycystic ovary syndrome (PCOS)
200 mcg8 weeks30
Effects of chromium picolinate on beginning weight training students
1992 · M-CrPic · Male college-age students beginning a weight-lifting program
200 mcg12 weeks18
Effects of chromium picolinate on beginning weight training students
1992 · F-CrPic · Female college-age students beginning a weight-lifting program
200 mcg12 weeks12
[Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet]
1997 · chromium yeast · Obese, non-diabetic patients aged 45 ± 6 years undergoing a very-low-calorie diet and maintenance period
200 mcg26 weeks—
[Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet]
1997 · chromium-picolinate · Obese, non-diabetic patients aged 45 ± 6 years undergoing a very-low-calorie diet and maintenance period
200 mcg26 weeks—
A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving
2005 · chromium picolinate (CrPic) · Adults with atypical depression; most were overweight or obese
600 mcg8 weeks70
Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus
2010 · Chromium group · Adults aged 30–70 with type 2 diabetes mellitus, BMI 25–40, and fasting plasma glucose at screening of at least 125 mg/dL
1 mg24 weeks70
Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation
2007 · chromium · Adults aged 25–70 with type 2 diabetes mellitus
1 mg26 weeks38
Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus
2005 · Group A · Patients with type 2 diabetes mellitus
1 mg90 days30
Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus
2005 · Group B · Patients with type 2 diabetes mellitus
1 mg90 days30
Effects of niacin-bound chromium supplementation on body composition in overweight African-American women
1999 · niacin-bound chromium (verum period) · overweight African-American women participating in a modest diet-and-exercise regimen
600 mcg60 days18
A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study
2013 · high dose · Adults aged 18–60 with binge eating disorder and BMI 25–45; mostly women
1 mg26 weeks7
A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study
2013 · moderate dose · Adults aged 18–60 with binge eating disorder and BMI 25–45; mostly women
600 mcg26 weeks7
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
1997 · 1.92 micromol (100 microg) Cr as chromium picolinate two times per day · Men and women with type 2 diabetes receiving treatment
200 mcg120 days—
Chromate-allergic patients challenged orally with potassium dichromate
1994 · potassium dichromate challenge · 30 patients with positive patch tests to potassium dichromate
2.5 mg1 day30
Trivalent chromium versus baricitinib for rheumatoid arthritis treatment: first phase 2/3 randomized controlled trial, is trivalent chromium the upcoming immune-modulator?
2024 · Group A (intervention group; trivalent chromium) · Adults with rheumatoid arthritis; predominantly female; mean age 42.9 years in this group
0.0035 mg/kg12 weeks20
Chromium Supplementation Reduces Resting Heart Rate in Patients with Metabolic Syndrome and Impaired Glucose Tolerance
2018 · Cr-enriched yeast · Patients with metabolic syndrome and impaired glucose tolerance; age and sex not specified
300 mcg——
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
1997 · 9.6 micromol (500 microg) Cr two times per day · Men and women with type 2 diabetes receiving treatment
1 mg120 days—
[Clinical assessment of dietary correction of metabolic syndrome by using specialized food product enriched with chrome]
2013 · Main group · Adults aged 30–65 years with metabolic syndrome
66 mcg26 weeks20
Effects of an amylopectin and chromium complex on the anabolic response to a suboptimal dose of whey protein
2017 · WPACr (whey protein isolate + Velositol test product) · Healthy men and women aged 22–34 years
2 g1 day10
Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss
2004 · Group B · Adults aged 21–50 with moderate obesity (BMI >26 kg/m²)
4 mg8 weeks—
Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control
2005 · group B · Obese adults with BMI 30–50.8 kg/m²
4 mg8 weeks—
[Efficacy of tianmaixiaoke tablets in the treatment of newly diagnosed type 2 diabetes mellitus in China]
2012 · study group · Adults with newly diagnosed type 2 diabetes mellitus; age and sex not reported
480 mg24 weeks42
Effects of a Scutellaria baicalensis/Crataegus laevigata, magnesium and chromium supplement on stressed individuals: A randomised, double-blind, placebo-controlled, crossover trial
2025 · herbal supplement · Adults aged 18–75, male and female, otherwise healthy and self-reporting stress (PSS score ≥13)
40 mcg15 days35
Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
2015 · chromium picolinate supplements · Women with polycystic ovary syndrome (PCOS)
200 mcg8 weeks32
A comparative study to assess the use of chromium in type 2 diabetes mellitus
2023 · chromium supplement group · Patients aged 40–60 years with uncontrolled type 2 diabetes mellitus
400 mcg90 days30
The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects
1990 · chromium picolinate · Adult volunteer subjects; sex and age range not reported; no condition stated
200 mcg6 weeks28
In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial
2010 · chromium-nicotinate group · HIV-positive adults with insulin resistance and elevated glucose, lipids, or evidence of body-fat redistribution
400 mcg16 weeks23
The effects of chromium and vitamin D(3) co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial
2020 · CrPic supplement · patients with type 2 diabetes mellitus; age and sex not stated
500 mcg120 days23
Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
2021 · chromium picolinate group · Adults aged 20–65 with nonalcoholic fatty liver disease
400 mcg12 weeks23
A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial
2021 · chromium picolinate · Patients with nonalcoholic fatty liver disease (NAFLD); age and sex not reported
400 mcg90 days23
Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients
2011 · Cr brewer's yeast · Adults aged 37–63 with type 2 diabetes
500 mcg8 weeks20
The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial
2018 · chromium group · Women aged 18–40 with infertility and polycystic ovary syndrome who were candidates for in vitro fertilization
200 mcg8 weeks20
Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus
2006 · Cr-enriched yeast group · Adults with type 2 diabetes mellitus; mean age 61.3 years; 9 men and 27 women across the study
400 mcg12 weeks19
Effects of acute chromium supplementation on postprandial metabolism in healthy young men
2004 · 400 microg chromium group · Apparently healthy, non-smoking young men with normal body mass index
400 mcg1 day13
Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study
2000 · chromium polynicotinate · Hypercholesterolemic subjects with total cholesterol 210–300 mg/dL; age and sex not reported
400 mcg8 weeks10
The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes
2000 · CrCl3 · People with type 2 diabetes; age and sex not specified
200 mcg8 weeks—
The effects of chromium and copper supplementation on mitogen-stimulated T cell proliferation in hypercholesterolaemic postmenopausal women
2002 · 200 microg Cr · Hypercholesterolaemic postmenopausal women
200 mcg12 weeks—
The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
2006 · chromium-containing milk powder group · Adults aged 30 to 75 years with type 2 diabetes mellitus, taking gliclazide
400 mcg16 weeks—
Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-α, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study
2012 · chromium dinicocysteinate · Adults aged 25–65 with type 2 diabetes
400 mcg90 days—
Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-α, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study
2012 · chromium picolinate · Adults aged 25–65 with type 2 diabetes
400 mcg90 days—
Improving the endothelial dysfunction in type 2 diabetes with chromium and vitamin D(3) byreducing homocysteine and oxidative stress: A randomized placebo-controlled trial
2020 · group III: chromium picolinate (CrPic) · People with type 2 diabetes mellitus; age and sex not stated
500 mcg120 days—
Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial
2007 · chromium picolinate and biotin combination (CPB) · Adults with type 2 diabetes mellitus and HbA1c ≥7%; supplemental analyses included participants with hypercholesterolemia and participants using stable doses of statins
600 mcg90 days226
Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial
2016 · Chromium picolinate group · Women with polycystic ovary syndrome; age range not reported
1 mg26 weeks44
Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study
2015 · supplemented · Patients with poorly controlled type 2 diabetes mellitus (HbA1c >7%); age and sex not reported
600 mcg120 days32
Synchronizing positive effect of vitamin C and chromium on hyper lipidemia, hyperglycemia, liver enzymes and BMI of diabetes mellitus type 2 patients
2024 · treatment group · Adults with type 2 diabetes mellitus; age range and sex breakdown for this arm not specified
200 mcg—30
Effects of acute chromium supplementation on postprandial metabolism in healthy young men
2004 · 800 microg chromium group · Apparently healthy, non-smoking young men with normal body mass index
800 mcg1 day13
Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study
2000 · combination of chromium polynicotinate and grape seed extract · Hypercholesterolemic subjects with total cholesterol 210–300 mg/dL; age and sex not reported
400 mcg8 weeks10
A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation
2017 · MOD · Overweight individuals with binge-eating disorder; age and sex not specified
600 mcg26 weeks9
A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation
2017 · HIGH · Overweight individuals with binge-eating disorder; age and sex not specified
1 mg26 weeks8
The effects of chromium and copper supplementation on mitogen-stimulated T cell proliferation in hypercholesterolaemic postmenopausal women
2002 · 200 microg Cr and 3.0 mg Cu · Hypercholesterolaemic postmenopausal women
200 mcg12 weeks—
Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial
1991 · chromium group · Men taking beta-blockers, mainly for hypertension
600 mcg8 weeks—
Effect of chromium supplementation on glucose tolerance and lipid profile
2000 · Chromium supplement · Normal, free-living adults; age and sex not specified
200 mg8 weeks44
The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes
2000 · Brewer's yeast · People with type 2 diabetes; age and sex not specified
23.3 mcg8 weeks—
Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes
2011 · study group · People with newly onset type-2 diabetes
42 mcg90 days—
Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial
2020 · supplement group · Overweight women with polycystic ovary syndrome (PCOS)
200 mcg12 weeks27
A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial
2015 · Dietary supplement (Glycabiane) · Adults aged 25–65 years, overweight or obese, with pre-diabetes/impaired fasting glucose
20 mcg120 days26
The effects of chromium and vitamin D(3) co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial
2020 · both vitamin D3 and CrPic · patients with type 2 diabetes mellitus; age and sex not stated
500 mcg120 days23
Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial
2025 · Cr-800 · Sedentary men and women aged 30–65 with overweight/obesity and at least two risk factors for metabolic syndrome
800 mcg12 weeks23
Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial
2025 · Cr-400 · Sedentary men and women aged 30–65 with overweight/obesity and at least two risk factors for metabolic syndrome
400 mcg12 weeks18
Impact of a mineral enriched, fiber complex on glycaemic response and satiation in healthy adults: a double-blind, crossover intervention study
2025 · SBD (SlimBiome® + dextrose) · Healthy men and women aged 18–65 years with normal fasting glucose and BMI 18.5–24.9 kg/m²
15 mcg1 day16
The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial
2006 · Chromium picolinate and biotin · People with type 2 diabetes and suboptimal glycemic control despite oral antihyperglycemic agents
600 mcg4 weeks—
Improving the endothelial dysfunction in type 2 diabetes with chromium and vitamin D(3) byreducing homocysteine and oxidative stress: A randomized placebo-controlled trial
2020 · group IV: vitamin D3 and CrPic · People with type 2 diabetes mellitus; age and sex not stated
500 mcg120 days—
Efficacy and Tolerability of a Food Supplement Based on Zea mays L., Gymnema sylvestre (Retz.) R.br.ex Sm, Zinc and Chromium for the Maintenance of Normal Carbohydrate Metabolism: A Monocentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
2024 · Group 1 (two FS tablets) · Adults aged 18–75 years, either sex, with mildly impaired fasting blood glucose (98–125 mg/dL)
40 mg90 days27
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
2019 · Nutraceutical A · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded.
10 mcg6 weeks24